Your browser doesn't support javascript.
loading
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
Coates, Laura C; Mease, Philip; Kronbergs, Andris; Helt, Cameron; Sandoval, David; Park, So Young; Combe, Bernard; Nash, Peter; Deodhar, Atul.
Afiliação
  • Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
  • Mease P; Swedish Medical Center/Providence St, Joseph Health and University of Washington, Seattle, WA, USA.
  • Kronbergs A; Eli Lilly and Company, Indianapolis, IN, USA.
  • Helt C; Eli Lilly and Company, Indianapolis, IN, USA.
  • Sandoval D; Eli Lilly and Company, Indianapolis, IN, USA.
  • Park SY; Eli Lilly and Company, Indianapolis, IN, USA.
  • Combe B; University of Montpellier, Montpellier, France.
  • Nash P; Department of Medicine, University of Queensland, Queensland, Brisbane, Australia.
  • Deodhar A; Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd, Portland, OR, 97239, USA. deodhara@ohsu.edu.
Clin Rheumatol ; 41(10): 3035-3047, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35674861
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Artrite Psoriásica / Antirreumáticos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Rheumatol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Artrite Psoriásica / Antirreumáticos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Clin Rheumatol Ano de publicação: 2022 Tipo de documento: Article